Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation
Methods and compositions for the prevention and treatment of liver damage or disease in a subject in need thereof are provided. The methods involve providing the sulfated oxysterol 25-hydroxycholesterol-3-sulfate (25HC3S) to the subject e.g. by 1) administering 25HC3S to the subject; or 2) overexpressing, in the subject, the hydroxysterol sulfotransferase enzyme SULT2B1b, which catalyzes the sulfation of 25-hydroxycholesterol (25HC) to form 25HC3S.
1. A method for promoting liver cell proliferation or liver tissue regeneration in a subject, comprising:
i) identifying a subject in need of at least one of liver cell proliferation and liver tissue regeneration, and
ii) elevating a level of 25-hydroxycholesterol-3-sulfate (25HC3S) in said subject by administering to said subject a composition comprising
25HC3S and
a physiologically compatible carrier,
wherein said subject does not have hyperlipidemia, and wherein said elevating promotes proliferation of liver cells or regeneration of liver tissue in said subject.
2. The method of claim 1 wherein the 25HC3S is administered in an amount ranging from 0.1 mg/kg to 100 mg/kg, based on body mass of said subject.
3. The method of claim 1 wherein the 25HC3S is administered in an amount ranging from 1 mg/kg to 10 mg/kg, based on body mass of said subject.
4. The method of claim 1 wherein the administration comprises at least one of oral administration, enteric administration, sublingual administration, transdermal administration, intravenous administration, peritoneal administration, parenteral administration, administration by injection, subcutaneous injection, and intramuscular injection.
5. The method of claim 1 wherein said step of elevating is performed before, during or after liver surgery in said subject.
6. The method of claim 5 wherein the liver surgery comprises liver transplant surgery.
7. The method of claim 1 wherein said subject has at least one of liver injury, and hepatitis.
8. The method of claim 1 , wherein said subject has viral hepatitis or autoimmune hepatitis.
9. The method of claim 1 , wherein said subject has liver inflammation caused by a virus, a poison, a drug, or a hereditary condition.
10. The method of claim 1 , wherein said subject has liver inflammation caused by a drug selected from the group consisting of amiodarone, an antiviral drug, aspirin, a corticosteroid, methotrexate, tamoxifen, and tetracycline.
11. The method of claim 4 , wherein said administration comprises oral administration.